Cancer Melanoma - Search News

Melanoma vaccine reduces death or cancer recurrence

A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

Moderna and Merck reported on Oct. 22 that a customized cancer vaccine for people with late-stage melanoma can reduce the risk of cancer recurrence or death over two years by 42% compared to current t...

· 1d · on MSN

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

ABC News · 1d

Breakthrough cancer vaccine reduces melanoma from returning by 42%, data shows

· 1d

World first personalised cancer vaccine stops disease returning in major trial

A new personalised cancer vaccine given alongside a widely used immunotherapy drug has cut the risk of patients dying or their skin cancer returning by 42% in a major clinical trial.

Wall Street Journal · 1d

Moderna’s Cancer Vaccine Success Doesn’t Live Up to Early Hype

· 1d

World-first personalised cancer vaccine slashes risk of death and disease returning

1don MSN

A personalized cancer vaccine could be available as soon as 2027. Here’s what we know

Moderna and Merck are preparing to seek regulatory approval after their experimental melanoma vaccine delivered promising results in a late-stage clinical trial. A breakthrough treatment for the deadliest form of skin cancer can cut a patient’s risk of recurrence or death nearly in half.

First-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients

“This is the first step,” said Dr. Robert Vonderheide, president-elect of the American Association for Cancer Research and director of the Abramson Cancer Center at the University of Pennsylvania. “Will it work in other tumors? I’m hopeful. Do we have a lot to learn? For sure.”

3don MSN

Norah O'Donnell: What I learned from my melanoma diagnosis

More people are diagnosed with skin cancer each year in the U.S. than all other cancers combined.